You Searched For "merck" and got 20 results
Sort By:
2 mins read
Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunis…
PTI Â Â
2 mins read
Sun Pharma gets emergency use authorization to manufacture Merck's anti-Covid pill Molnupiravir
Amid the ongoing resurgence of new Covid-19 cases in India, an expert panel of the Central Dru…
2 mins read
The 2 factors that will determine if Omicron is a true threat, according to Pfizer's top scientist
These are Insider's biggest healthcare stories for December 1.
Leah Rosenbaum  Â
4 mins read
An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns
A COVID-19 pill could prevent infected people from getting seriously sick. But the FDA panel expres…
Andrew Dunn,Andrea Michelson  Â
2 mins read
What's ahead for COVID-19 treatments after Pfizer says its antiviral pill works
These are Insider's biggest healthcare stories for the week ending November 5.
Leah Rosenbaum  Â
1 min read
A new pill designed to treat active COVID-19 infections was just approved by the UK, the first country to do so
Early trial results found that Merck's molnupiravir, the first antiviral designed to treat COVID-19…
Mary Hanbury  Â
4 mins read
Merck is set to make billions off a COVID-19 pill that could change the pandemic. Here's why some countries will pay more than others.
Merck's antiviral has not yet been authorized, but the company already has plans to distribute the …
Andrew Dunn  Â
1 min read
Merck says it'll ask regulators to authorize the first antiviral pill designed to treat COVID-19 after a trial found it halved the risk of hospitalization or death
Merck and Ridgeback on Friday morning said they'd apply for emergency FDA authorization for the dru…
Grace Dean  Â
2 mins read
Merck will reportedly help produce Johnson & Johnson COVID-19 vaccine shots after failing to make its own
The Washington Post reported that President Joe Biden would announce the partnership between the tw…
Allana Akhtar  Â
2 mins read
US drug giant Merck drops out the COVID-19 vaccine race, after its 2 vaccine candidates failed to generate a strong immune response
Merck said the vaccines failed to produce an adequate immune response. It would focus on two new CO…
Dr. Catherine Schuster-Bruce  Â
2 mins read
What's in store for the next wave of vaccines
These are Business Insider's biggest healthcare stories for January 25.
Lydia Ramsey Pflanzer  Â
1 min read
Retail investors are dumping shares of COVID-19 vaccine makers and piling into antiviral pill maker Merck, data shows
Merck shares have jumped since the drug maker said molnupiravir cuts the risk of COVID hospitalizat…
Carla MozĂ©e  Â
2 mins read
Merck jumps 10% as the drugmaker says its antiviral pill cuts the risk of hospitalizations and deaths in COVID patients
Merck already has a deal to supply 1.7 million courses of antiviral pill molnupiravir to the US gov…
Carla MozĂ©e  Â
2 mins read
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…
Matthew Fox  Â
1 min read
Pandion Therapeutics soars 132% after Merck agrees to buy the biotech for $1.85 billion
Pandion is a clinical-stage biotechnology company that is developing therapeutics for patients livi…
Matthew Fox  Â
3 mins read
The FDA could authorize the first COVID-19 pill in December - here's who may be eligible
Next month, the FDA will meet to discuss Merck's antiviral pill for adults with mild to moderate CO…
Aria Bendix  Â
1 min read
Merck requests FDA authorization for its anti-COVID-19 pill, the next step towards rolling it out
The pill "significantly reduced the risk of hospitalization or death," according to the developers …
Marianne Guenot  Â
4 mins read
The first-ever COVID-19 pill may be just weeks away. A handful of other pills, inhalers, and nasal sprays also show promise.
Easy-to-take coronavirus treatments could complement vaccines. These are the most promising ones to…
Aria Bendix,Andrew Dunn  Â
3 mins read
HR leaders should focus on technology innovation to support employee experience, according to Merck CHRO
Merck's CHRO shares how to improve digital tools at your company by focusing on business outcomes a…
Sharon Goldman  Â
2 mins read
Warren Buffett's Berkshire Hathaway sold Biogen, halved its Merck stake, and boosted its Kroger bet. Here's a closer look at its key trades in Q2.
Buffett's company established stakes in Merck, AbbVie, and Bristol Myers Squibb in the second half …